In patients with an aggressive form of breast cancer, treatment with the antibody-drug conjugate sacituzumab govitecan plus ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

In calling for more clinical testing of vaccines in younger people and those who face a low risk of severe disease from Covid ...

Science Connected Magazine is an editorially independent, non-profit newsroom producing open-access science journalism and scientific fact-checking for the global public.

Researchers at the Ragon Institute have made a significant discovery about how antibodies can directly enhance the body's ...

Bristol Myers Squibb partners with BioNTech in a $11.1B deal to develop BNT327, a promising cancer immunotherapy. Read more ...

Researchers at the Ragon Institute have made a significant discovery about how antibodies can directly enhance the body's ...

The TIGOS trial: A randomized, double-blind phase 3 trial of atigotatug + nivolumab fixed-dose combination with chemotherapy vs atezolizumab with chemotherapy in patients with 1L extensive-stage small ...

Merck's ( NYSE: MRK) experimental antibody drug conjugate zilovertamab vedotin, in combination with standard of care, ...

Safety and efficacy of OR502, an antibody targeting leukocyte immunoglobulin-like receptor B2 (LILRB2), ± cemiplimab in patients with advanced solid tumors from a phase 1 study. Phase 1b dose ...

Bristol Myers Squibb is partnering with BioNTech on a closely watched cancer drug, in a deal worth billions of dollars.

The birds amassed fans, as legions of devotees follow along on webcams each spring as falcons progress from hatching to ...